Literature DB >> 12398209

Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease.

Arlette Darfeuille-Michaud1.   

Abstract

Crohn's disease (CD) is an inflammatory bowel disease (IBD) of unknown aetiology. Genetically engineered rodent models showed that IBDs are immunologically mediated and that luminal bacteria play an essential role in the development of the inflammation. Various bacterial pathogens have been incriminated but results have been conflicting. A new pathovar of E. coli, designated adherent-invasive Escherichia coli (AIEC) may be associated with CD. AIEC strains colonize the intestinal mucosa by adhering to intestinal epithelial cells. They are also true invasive pathogens, able to invade intestinal epithelial cells via a macropinocytosis-like process, and to survive and replicate intracellularly after lysis of the endocytic vacuole. Within macrophages, AIEC strains survive and replicate extensively without inducing host cell death and induce the release of high amounts of TNFalpha. All these virulence properties designate AIEC as a possible pathogen potentially able to induce persistent intestinal inflammation, by crossing and breaching the intestinal barrier, moving to deep tissues, and continuously activating macrophages.

Entities:  

Mesh:

Year:  2002        PMID: 12398209     DOI: 10.1078/1438-4221-00201

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  54 in total

Review 1.  Crohn's disease and infections: a complex relationship.

Authors:  Gert De Hertogh; Karel Geboes
Journal:  MedGenMed       Date:  2004-08-10

2.  A molecular revolution in the study of intestinal microflora.

Authors:  E Furrie
Journal:  Gut       Date:  2006-02       Impact factor: 23.059

Review 3.  Toll like receptor-5: protecting the gut from enteric microbes.

Authors:  Matam Vijay-Kumar; Jesse D Aitken; Andrew T Gewirtz
Journal:  Semin Immunopathol       Date:  2007-12-07       Impact factor: 9.623

4.  Origin and Evolution of Hybrid Shiga Toxin-Producing and Uropathogenic Escherichia coli Strains of Sequence Type 141.

Authors:  Noble Selasi Gati; Barbara Middendorf-Bauchart; Stefan Bletz; Ulrich Dobrindt; Alexander Mellmann
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

Review 5.  Microbial biofilms and gastrointestinal diseases.

Authors:  Erik C von Rosenvinge; Graeme A O'May; Sandra Macfarlane; George T Macfarlane; Mark E Shirtliff
Journal:  Pathog Dis       Date:  2013-01-29       Impact factor: 3.166

Review 6.  Immunopathology of inflammatory bowel disease.

Authors:  Kori L Wallace; Li-Bo Zheng; Yoshitake Kanazawa; David Q Shih
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 7.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

8.  NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation.

Authors:  Rachel Cooney; John Baker; Oliver Brain; Benedicte Danis; Tica Pichulik; Philip Allan; David J P Ferguson; Barry J Campbell; Derek Jewell; Alison Simmons
Journal:  Nat Med       Date:  2009-12-06       Impact factor: 53.440

9.  Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers.

Authors:  Carol L Roberts; Asa V Keita; Sylvia H Duncan; Niamh O'Kennedy; Johan D Söderholm; Jonathan M Rhodes; Barry J Campbell
Journal:  Gut       Date:  2010-09-02       Impact factor: 23.059

Review 10.  Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease.

Authors:  In-Ah Lee; Alan Kamba; Daren Low; Emiko Mizoguchi
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.